Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Massive data screening is a second opportunity to improve the management of patients with familial hypercholesterolemia phenotype.

Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis - 1 Jan 2000

Zamora Alberto, Paluzie Guillem, García-Vilches Joan, Alonso Gisbert Oriol, Méndez Martínez Ana Inés, Plana Núria, Rodríguez-Borjabad Cèlia, Ibarretxe Daiana, Martín-Urda Anabel, Masana Luis

Abstract excerpt

INTRODUCTION: Familial Hypercholesterolemia (FH) is an autosomal dominant disease with an estimated prevalence between 1/200-250. It is under-treated and underdiagnosed. Massive data screening can increase the detection of patients with FH. METHODS: Study population: Residents in the health coverage area (N: 195.000 inhabitants) and with at least one determination of cholesterol linked to low-density lipoproteins...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Cholesterol

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholesterol, LDL

Share to Hyperlipoproteinemia Type II

Share to Mass Screening

Share to Phenotype

Source

Identifiers

PMID: 33618913
DOI: 10.1016/j.arteri.2020.11.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Massive data screening is a second opportunity to improve the management of patients with familial hypercholesterolemia phenotype.PMID 33618913Read ↗

Enhanced identification of familial hypercholesterolemia using central laboratory algorithms.Semantic proximity Read ↗

Familial Hypercholesterolemia Identification by Machine Learning Using Lipid Profile Data Performs as Well as Clinical Diagnostic Criteria.Semantic proximity Read ↗

FH ALERT: A feasibility study of a novel approach to identify patients with familial hypercholesterolemiaSemantic proximity Read ↗

Incidence of Cardiovascular Disease in Patients with Familial Hypercholesterolemia Phenotype: Analysis of 5 Years Follow-Up of Real-World Data from More than 1.5 Million PatientsSemantic proximity Read ↗

Large-scale functional characterization of low-density lipoprotein receptor gene variants improves risk assessment in cardiovascular diseaseSemantic proximity Read ↗

Simplified Criteria for Identification of Familial Hypercholesterolemia in Children: Application in Real LifeSemantic proximity Read ↗

Limited-Variant Screening vs Comprehensive Genetic Testing for Familial Hypercholesterolemia DiagnosisSemantic proximity Read ↗

A machine learning model to aid detection of familial hypercholesterolaemiaSemantic proximity Read ↗

Detection of familial hypercholesterolemia in patients from a general practice database.Semantic proximity Read ↗

Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.Semantic proximity Read ↗

Improving the Detection of Potential Cases of Familial Hypercholesterolemia: Could Machine Learning Be Part of the Solution?Semantic proximity Read ↗

Rapid identification of familial hypercholesterolemia from electronic health records: The SEARCH study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.